Table 3.

Patients' characteristics by race/ethnicity in the transcriptional profiles cohort

TotalBlackHispanicWhiteOther
N (%)N (%)N (%)N (%)N (%)
Characteristic376 (100%)32 (8.5%)111 (29.5%)216 (57.5%)17 (4.5%)P
Age at diagnosis
 Minimum2632292638
 Median5049485150
 Maximum80757780690.0722
Subtype
 Hormone receptor–positive204 (54.26%)13 (40.63%)58 (52.25%)122 (56.04%)11 (64.71%)
 HER2-positive62 (16.49%)4 (12.50%)17 (15.32%)36 (16.67%)5 (29.41%)
 Triple negative110 (29.26%)15 (46.88%)36 (32.43%)58 (26.85%)1 (5.88%)0.0712
Menopausal status
 Pre/perimenopausal174 (46.28%)13 (40.63%)62 (55.86%)90 (41.67%)9 (52.94%)
 Postmenopausal198 (52.66%)19 (59.38%)46 (41.44%)125 (57.87%)8 (47.06%)0.0518
Histology
 Ductal360 (95.74%)31 (96.88%)108 (97.30%)205 (94.9%)16 (94.12%)
 Other16 (4.26%)1 (3.13%)3 (2.70%)11 (5.09%)1 (5.88%)0.6388
Nuclear grade
 124 (6.38%)2 (6.25%)2 (1.80%)19 (8.80%)1 (5.88%)
 2141 (37.50%)8 (25.00%)33 (29.73%)94 (43.52%)6 (35.29%)
 3180 (47.87%)22 (68.75%)46 (41.44%)102 (47.22%)10 (58.82%)0.1434
Stage
 I7 (1.86%)0 (0.00%)3 (2.70%)41.850 (0.00%)
 II192 (51.06%)13 (40.63%)30 (27.03%)137 (63.43%)12 (70.59%)
 III and IV176 (46.81%)19 (59.38%)78 (70.27%)74 (34.26%)5 (29.41%)<0.0001